Travere Therapeutics
TVTX
TVTX
196 hedge funds and large institutions have $1.66B invested in Travere Therapeutics in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more funds holding
Funds holding: 177 → 196 (+19)
2.56% more ownership
Funds ownership: 108.16% → 110.72% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
196
Holding in Top 10
3
Calls
$22.6M
Puts
$16.2M
Top Buyers
| 1 | +$70.1M | |
| 2 | +$50.6M | |
| 3 | +$33.2M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$21.1M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$20M |
Top Sellers
| 1 | -$38.8M | |
| 2 | -$24.9M | |
| 3 | -$18M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$14.7M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$7.84M |